Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?

Bibliographic Details
Main Authors:	Heidi Ko, Rebecca A. Previs, Kyle C. Strickland, Jonathan Klein, Brian Caveney, Chiara Chiruzzi, Marcia Eisenberg, Eric A. Severson, Shakti Ramkissoon, Kamal S. Saini
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2023-11-01
Series:	Oncology and Therapy
Subjects:	HER2-low Metastatic breast cancer HER2 testing HER2-directed antibody–drug conjugate
Online Access:	https://doi.org/10.1007/s40487-023-00249-0

Internet